Triamcinolone

A corticosteroid hormone receptor agonist.

Phase of research

Potential treatment - pre-clinical evidence

How it helps

Other treatment

Drug status

Used to treat other disease

1
Supporting references
0
Contradictory references
3
AI-suggested references
0
Clinical trials

General information

Triamcinolone is a synthetic glucocorticoid with immunomodulatory and anti-inflammatory activity. It activates glucocorticoid-responsive genes such as lipocortins, which prevents inflammation through inhibition of prostaglandin and leukotriene synthesis. Pro-inflammatory cytokine production (e. g. interleukin (IL)-1and IL-6) and the activation of cytotoxic T-lymphocytes is also inhibited. Triamcinolone also stimulates apoptosis (NCIt).

Triamcinolone on DrugBank
Triamcinolone on PubChem
Triamcinolone on Wikipedia


Marketed as

TRIAMCINONLONE ACETONIDE (also KENALOG; TRIDERM; ASACORT ALLERGY 24HOUR; TRIESENCE; ZILRETTA); ARISTOSPAN (TRIAMCINOLONE HEXACETONIDE)

 

Structure image - Triamcinolone

C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O


Supporting references

Link Tested on Impact factor Notes Publication date
Glucocorticoids improve severe or critical COVID-19 by activating ACE2 and reducing IL-6 levels
GES1 cells; M0 and M1 macrophages 4.86

Decreases IL-6 secretion in M1 macrophages in vitro.

Jun/27/2020

AI-suggested references